Haemonetics Corp (HAE)

Haemonetics Corp Azioni (HAE) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-09-26	2026-06-27	2026-03-28	2025-12-27	2025-09-27
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	5.42%357.76	339.38	346.35	338.97	327.32
Cost Of Revenue	0.20%136.85	136.58	148.14	136.58	132.57
Gross Profit	8.93%220.91	202.80	198.21	202.39	194.74
	0.31%145.79	145.35	221.24	134.99	136.25
Selling, General, and Administrative	0.49%118.36	118.94	120.93	109.15	101.62
Research and Development	5.12%17.03	16.20	14.45	14.19	14.87
Depreciation and Amortization	2.39%27.76	27.11	27.32	27.39	28.26
Operating Income/Loss	30.74%75.12	57.46	-23.03	67.40	58.49
Income/Loss From Equity Method Investments	40.00%-1.40	-1.00	-	-	-
Income/Loss From Continuing Operations Before Tax	32.13%62.86	47.57	-28.40	59.98	51.29
Income Tax Expense/Benefit, Deferred	284.13%2.57	0.67	-20.38	-2.06	-0.73
Income Tax Expense/Benefit	13.66%16.55	14.56	-8.25	15.24	12.60
	40.28%46.31	33.01	-20.15	44.74	38.68
Attributable To Parent	40.28%46.31	33.01	-20.15	44.74	38.68
Basic Average Shares	0.31%45.50	45.36	-	46.79	47.59
Diluted Average Shares	1.66%46.46	45.70	-	46.99	47.66
Basic Earnings Per Share	39.73%1.02	0.73	-	0.96	0.81
Diluted Earnings Per Share	38.89%1.00	0.72	-	0.95	0.81